|
Jan 21
|
Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer
|
|
Jan 6
|
Teoxane Offers $3.60 per Share to Acquire Revance Therapeutics, Topping Prior Crown Labs Bid
|
|
Jan 6
|
Teoxane SA Announces Superior Proposal to Acquire Revance Therapeutics for $3.60 per Share in Cash
|